DRI Capital Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
21
- Investments
-
1
- Portfolio
-
1
DRI Capital General Information
Description
Founded in 1992, DRI Capital is a private equity firm based in Toronto, Canada. The firm focuses on private equity funds that purchase royalties from pharmaceutical and biotechnology firms, research institutions, universities, inventors, medical devices, diagnostic products, and life science tools and technologies.
Contact Information
Formerly Known As
Drug Royalty Corporation
Year Founded
1992
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Primary Office
- 100 King Street West, Suite 7250
- Post Office Box 62
- Toronto, Ontario M5X 1B1
- Canada
+1 (416) 000-0000
DRI Capital Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 000 000000000 00 0 | 02-Feb-2016 | 0000000000 | Buildings and Property |
DRI Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
DRI Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
DRI Capital Team (53)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Behzad Khosrowshahi | Chief Executive Officer & Board of Trustees | 0 | 0 | Toronto, Canada | |
| Chris Anastasopoulos | Chief Financial Officer & Executive Vice President | Toronto, Canada | |||
| Stewart Busbridge | Executive Vice President & Chief Operating Officer | 0 | Toronto, Canada | ||
| Faith Bowen | Chief Compliance Officer | Toronto, Canada | |||
| Joel Herold JD | Executive Vice President & Chief Legal Officer | 0 | Toronto, Canada |